BIO-PATH HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.14 USD | -8.55% |
|
-21.32% | -76.89% |
| May. 15 | Transcript : Bio-Path Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024 | |
| Apr. 19 | Bio-Path Closes $1.2 Million Share Offering | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 29.5 | 15.9 | 26.99 | 12.02 | 5.719 | 3.35 | - | - |
| Enterprise Value (EV) 1 | 29.5 | 15.9 | 26.99 | 12.02 | 5.719 | 3.35 | 3.35 | 3.35 |
| P/E ratio | -2.47 x | -1.24 x | -2.43 x | -0.79 x | -0.01 x | -0.22 x | -0.27 x | -0.28 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 185 | 227 | 358 | 398 | 618 | 1,565 | - | - |
| Reference price 2 | 159.8 | 70.00 | 75.40 | 30.20 | 9.260 | 2.140 | 2.140 | 2.140 |
| Announcement Date | 3/5/20 | 3/9/21 | 3/10/22 | 3/30/23 | 3/7/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -8.693 | -10.91 | -10.44 | -13.9 | -15.84 | -13.46 | -14.13 | -14.36 |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -8.599 | -10.88 | -10.44 | -13.87 | -16.08 | -13.41 | -14.07 | -14.25 |
| Net income 1 | -8.599 | -10.88 | -10.44 | -13.87 | -16.08 | -13.41 | -14.07 | -14.25 |
| Net margin | - | - | - | - | - | - | - | - |
| EPS 2 | -64.80 | -56.60 | -31.00 | -38.20 | -672.6 | -9.680 | -8.000 | -7.710 |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/5/20 | 3/9/21 | 3/10/22 | 3/30/23 | 3/7/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -4.117 | -3.359 | -3.01 | -3.546 | -3.986 | -5.292 | -4.242 | -3.276 | -3.033 | -3.695 | -3.225 | -3.253 | -3.281 |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -4.116 | -3.359 | -3.008 | -3.535 | -3.966 | -5.273 | -4.234 | -3.199 | -3.372 | -3.157 | -3.208 | -3.239 | -3.271 |
| Net income 1 | -4.116 | -3.359 | -3.008 | -3.535 | -3.966 | -5.273 | -4.234 | -3.199 | -3.372 | -3.157 | -3.208 | -3.239 | -3.271 |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -11.80 | -9.400 | -8.400 | -9.800 | -10.60 | -13.20 | -10.60 | -6.400 | -84.60 | -4.880 | -2.060 | -1.950 | -1.950 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/10/22 | 5/16/22 | 8/15/22 | 11/14/22 | 3/30/23 | 5/11/23 | 8/14/23 | 11/14/23 | 3/7/24 | 5/14/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - | - |
| Announcement Date | 3/5/20 | 3/9/21 | 3/10/22 | 3/30/23 | 3/7/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.14
USD
Average target price
20
USD
Spread / Average Target
+834.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -76.89% | 3.35M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
- Stock Market
- Equities
- BPTH Stock
- Financials Bio-Path Holdings, Inc.
